TCTR20150422001招募中未知
Pulmonary manifestation in systemic sclerosis in Srinagarind Hospital
MDResearch.kku0 个研究点目标入组 300 人开始时间: 2015年4月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 100 Years（—）
- 性别
- All
入选标准
- •1.systemic sclerosis from criteria of ACR1980 or ACR/EULAR 2013
- •2.visit Scleroderma Clinic in Srinagarind Hospital during 1 Jan 2012 until 31 Dec 2014
- •3.done HRCT chest
- •4.age not less than 18
排除标准
- •1.systemic sclerosis with overlapping syndrome
研究者
相似试验
进行中（未招募）
1 期
Systemic sclerosis associated interstitial lung disease: A longitudinal observational study assessing optimum treatment regimens. - Assessment of scleroderma lung diseaseSystemic Sclerosis associated interstitial lung diseaseMedDRA version: 9.1Level: LLTClassification code 10042953Term: Systemic sclerosisEUCTR2008-000224-27-GBewcastle upon Tyne NHS Foundation Trust20
终止
不适用
In Vivo Endomicroscopic Description of Pulmonary Microcirculation in Systemic Sclerosis and Emphysema PatientsPulmonary DiseasePulmonary EmphysemaNCT02556697University Hospital, Rouen9
招募中
不适用
Interstitial Lung Disease Trajectories in Patients With Systemic SclerosisInterstitial Lung DiseaseSystemic SclerosisNCT05345795Central Hospital, Nancy, France600
Unknown
不适用
Development and Prevention of Pulmonary Hypertension in Systemic SclerosisPulmonary HypertensionSystemic SclerosisNCT01840748University of Paris 5 - Rene Descartes960
已完成
不适用
Endothelial Microparticles in Systemic Sclerosis Pulmonary HypertensionSclerodermaSystemic SclerosisPulmonary HypertensionNCT02331225Louisiana State University Health Sciences Center in New Orleans30